The Effect of Syringe Type on Adverse Effect Following Immunization.

Not Applicable

• Conditions: Condition 1: sever local reaction following immunization. Condition 2: sever local reaction following immunization.; Infection following immunization; Other complications following immunization, not elsewhere classified

• Registration Number: IRCT201107317171N1
• Lead Sponsor: Shahroud University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

All children who are eligible for DTP vaccination can be registered in this study. every eligible child is not enrolled in study If DTP vaccination is contraindicated, his/her parents denied to sign informed consent or the child is not accessible for follow up of AEFI (adverse effects following immunization ).

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Erythema. Timepoint: days 2, 4 and 6 following immunization. Method of measurement: By health care professional and/or physician.;Oedema. Timepoint: days 2, 4 and 6 following immunization. Method of measurement: By health care professional and/or physician.;Pain. Timepoint: days 2, 4 and 6 following immunization. Method of measurement: By health care professional and/or physician.;Fever. Timepoint: days 2, 4 and 6 following immunization. Method of measurement: By health care professional and/or physician.

Secondary Outcome Measures

Name	Time	Method
Sever local reaction AND Injection-Site Abscess. Timepoint: Days 2, 4, and 6 after immunization. Method of measurement: By health care professional and/or physician.